Isolation perfusion with @entity900 for malignant XXXX of the limbs.

@entity1 @entity900 @entity320 @entity137
The role of hyperthermic isolation perfusion in the treatment of advanced @entity320 of the limbs is clearly important. However, attention has in the past been focussed mainly on surgical aspects of the procedure. Whereas, equivalent interest in chemotherapy considerations has been lacking. A group of 15 @entity1 have been treated by hyperthermic isolated perfusion for advanced @entity320 of the limbs. The chemotherapeutic agent used was @entity900 . The follow-up period was 6 to 60 months. None of these @entity1 had any sign or symptoms of @entity137 from the drug. Twelve of these 15 @entity1 are free of disease currently. There was one case of mortality due to unrelated cause and two cases of mortality due to disseminated disease which developed 6 months and 30 months, respectively, posttreatment. Since not uncommon toxic side effects from other drugs used for this procedure is significant, these results suggest that @entity900 may be used as an alternative chemotherapeutic agent in isolation perfusion for advanced @entity320 of the extremities.
